BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

588 related articles for article (PubMed ID: 17414408)

  • 21. Combination antifungal therapy of murine aspergillosis: liposomal amphotericin B and micafungin.
    Graybill JR; Bocanegra R; Gonzalez GM; Najvar LK
    J Antimicrob Chemother; 2003 Oct; 52(4):656-62. PubMed ID: 12972452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.
    Herbrecht R; Denning DW; Patterson TF; Bennett JE; Greene RE; Oestmann JW; Kern WV; Marr KA; Ribaud P; Lortholary O; Sylvester R; Rubin RH; Wingard JR; Stark P; Durand C; Caillot D; Thiel E; Chandrasekar PH; Hodges MR; Schlamm HT; Troke PF; de Pauw B;
    N Engl J Med; 2002 Aug; 347(6):408-15. PubMed ID: 12167683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A case of Aspergillus mediastinitis after heart transplantation successfully treated with liposomal amphotericin B, caspofungin and voriconazole.
    Forestier E; Remy V; Lesens O; Martinot M; Hansman Y; Eisenmann B; Christmann D
    Eur J Clin Microbiol Infect Dis; 2005 May; 24(5):347-9. PubMed ID: 15889298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination antifungal therapy for invasive aspergillosis.
    Cesaro S; Visintin G
    Clin Infect Dis; 2005 Apr; 40(7):1073-5; author reply 1075-6. PubMed ID: 15825015
    [No Abstract]   [Full Text] [Related]  

  • 25. Voriconazole: new preparation. Invasive aspergillosis: benefits to be confirmed.
    Prescrire Int; 2004 Feb; 13(69):13-6. PubMed ID: 15055210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An update on the use of antifungal agents.
    Martinez R
    J Bras Pneumol; 2006; 32(5):449-60. PubMed ID: 17268750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Caspofungin for the treatment of azole resistant candidemia in a premature infant.
    Smith PB; Steinbach WJ; Cotten CM; Schell WA; Perfect JR; Walsh TJ; Benjamin DK
    J Perinatol; 2007 Feb; 27(2):127-9. PubMed ID: 17262048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cutaneous aspergillosis in a lung transplant recipient.
    Ramos A; Ussetti P; Laporta R; Lázaro MT; Sánchez-Romero I
    Transpl Infect Dis; 2009 Oct; 11(5):471-3. PubMed ID: 19622116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New agents for the treatment of fungal infections: clinical efficacy and gaps in coverage.
    Spanakis EK; Aperis G; Mylonakis E
    Clin Infect Dis; 2006 Oct; 43(8):1060-8. PubMed ID: 16983621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The future of antifungal agents].
    Maesaki S
    Rinsho Ketsueki; 2007 Jan; 48(1):26-35. PubMed ID: 17313074
    [No Abstract]   [Full Text] [Related]  

  • 31. Primary cutaneous aspergillosis in an immunocompetent patient: successful treatment with oral voriconazole.
    Craiglow B; Hinds G; Antaya R; Girardi M
    Pediatr Dermatol; 2009; 26(4):493-5. PubMed ID: 19689543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of newer antifungal therapies in clinical practice: what do the data tell us?
    Perfect JR
    Oncology (Williston Park); 2004 Nov; 18(13 Suppl 7):15-23. PubMed ID: 15651178
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Successful management of invasive aspergillosis with voriconazole and amphoteracin B therapy in a patient with acute mycloid leukemia (AML-M2).
    Manzoor NF; Azim S; Fadoo Z
    J Pak Med Assoc; 2010 Nov; 60(11):977-9. PubMed ID: 21375212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Successful treatment of concomitant pulmonary zygomycosis and aspergillosis with a combination of amphotericin B lipid complex, caspofungin, and voriconazole in a patient on immunosuppression for chronic graft-versus-host disease.
    Verma A; Williams S; Trifilio S; Zembower T; Mehta J
    Bone Marrow Transplant; 2004 May; 33(10):1065-6. PubMed ID: 15048146
    [No Abstract]   [Full Text] [Related]  

  • 35. Aspergillus fumigatus Meningitis in a Preterm.
    Phute SU; Bhakre JB
    Indian Pediatr; 2010 Nov; 47(11):980. PubMed ID: 21149907
    [No Abstract]   [Full Text] [Related]  

  • 36. Aspergillus fumigatus: a potentially lethal ubiquitous fungus in extremely low birthweight neonates.
    Langan EA; Agarwal RP; Subudhi CP; Judge MR
    Pediatr Dermatol; 2010; 27(4):403-4. PubMed ID: 20653867
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Economic evaluation of targeted treatments of invasive aspergillosis in adult haematopoietic stem cell transplant recipients in the Netherlands: a modelling approach.
    Ament AJ; Hübben MW; Verweij PE; de Groot R; Warris A; Donnelly JP; van 't Wout J; Severens JL
    J Antimicrob Chemother; 2007 Aug; 60(2):385-93. PubMed ID: 17561501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Breakthrough trichosporonosis in patients with hematologic malignancies receiving micafungin.
    Matsue K; Uryu H; Koseki M; Asada N; Takeuchi M
    Clin Infect Dis; 2006 Mar; 42(6):753-7. PubMed ID: 16477548
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Triple antifungal therapy for the treatment of invasive aspergillosis in a neutropenic pediatric patient.
    Sims-McCallum RP
    Am J Health Syst Pharm; 2003 Nov; 60(22):2352-6. PubMed ID: 14652986
    [No Abstract]   [Full Text] [Related]  

  • 40. Liposomal amphotericin-B (AmBisome) for treatment of disseminated fungal infections in two infants of very low birth weight.
    Lackner H; Schwinger W; Urban C; Müller W; Ritschel E; Reiterer F; Kuttnig-Haim M; Urlesberger B; Hauer C
    Pediatrics; 1992 Jun; 89(6 Pt 2):1259-61. PubMed ID: 1594386
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.